Bleomycin A5 Hydrochloride 8?mg Wholesale price comparison
$1.00
Bleomycin A5 (Pingyangmycin) is a glycopeptide antibiotic with potent antineoplastic and apoptosis-inducing properties. It’s widely used in preclinical oncology—especially in chemotherapy models, DNA damage studies, and sclerotherapy for vascular malformations. Supplied as an 8?mg vial of sterile freeze-dried powder.
?? For laboratory research use only. ?Please consult the staff for other purposes?
描述
Bleomycin A5 Product Specifications
| Attribute | Details |
|---|---|
| Generic Name | Bleomycin A5 Hydrochloride (Pingyangmycin) |
| CAS Number | 11116?32?8 |
| Molecular Formula | C??H??N??O??S?·HCl |
| Molecular Weight | ~1,440.6?Da (free base); ~1,477?Da (HCl salt) |
| Dosage Form | Lyophilized powder for injection |
| Strength | 8?mg per vial |
| Pack Size | 1 vial per box (adjustable) |
| Approval Number | H20123357 (NMPA, China) |
| Product Code | 86903506000737 |
| Manufacturer | Jilin Aodong Pharmaceutical Group Yanji Co., Ltd. |
| Barcode | 6930847126622 |
| Storage | Store at 2–8?°C, protected from moisture and light |
| Intended Use | Laboratory research use only |
Mechanism of Action
Bleomycin A5 intercalates into DNA and, in the presence of metal ions and oxygen, produces reactive oxygen species to induce strand breaks—triggering apoptosis and cell death. It exerts effects during the G2 phase of the cell cycle and shares cytotoxic pathways with bleomycin A2/B2 .
Research Applications & Pharmacology
-
Cancer research: Used in lymphoma, squamous cell carcinoma, testicular cancer, and experimental lung cancer models lktlabs.com.
-
Sclerotherapy models: Applied intralesionally for lymphatic and venous malformations—e.g., oral/maxillary venous malformations—at doses of 1–2?mg/mL, with demonstrated >80% lesion reduction .
-
Pharmacokinetics & toxicity: IV, IM, or intralesional administration; rapid effect on DNA; risk of pulmonary fibrosis and skin reactions; A5 variant has comparatively lower lung toxicity than A2 biosynth.com+15en.wikipedia.org+15cymitquimica.com+15.
Safety Profile & Handling
Adverse Effects in Research Context:
-
Pulmonary toxicity (dose-dependent interstitial fibrosis)
-
Skin toxicities: rash, hyperpigmentation
-
Fever, nausea, mucositis
-
Rare: anaphylaxis (<1%), leukopenia
Handling Guidelines:
-
Reconstitute with sterile saline (1–2?mg/mL)
-
Administer via IV or intralesional route under biosafety conditions
-
Follow PPE and cytotoxic-waste SOPs
-
Monitor pulmonary function in animal studies
?? Research?Use Disclaimer
This product is intended exclusively for laboratory research. It is not approved for therapeutic, clinical, diagnostic, or veterinary uses. Improper use may pose health hazards and affect research integrity.
其他信息
| 重量 | 1 公斤 |
|---|---|
| 尺寸 | 18 × 16 × 18 厘米 |
相关产品
-
Rilertinib Mesylate Tablets (Sanrisso®) – 100?mg × 20 Tablets per Bottle
Rilertinib mesylate (Sanrisso®), developed by Nanjing Sanhome Pharmaceutical Co., Ltd., is a third-generation EGFR-TKI approved by China's NMPA (Approval No. H20240020; Drug Code: 86901583000930). Each bottle contains 20 tablets of 100?mg each. Strictly for laboratory research use only—not for clinical or human use. $1.00 -
Reduced Glutathione Injection 0.6?g × 10 Vials – Ruiyang | Price comparison
Ruiyang Reduced Glutathione Injection (0.6?g per vial × 10) by Ruiyang Pharmaceutical Co., Ltd. Ideal for antioxidant, detoxification, and hepatic-protection research in metabolic and oxidative stress studies.
?? For laboratory research use only – Not for human consumption or therapeutic use. $2.00 -
Clodronate Disodium Capsules (Baiyunshan/Dewei) – 0.4?g × 10 Capsules Price comparison
Clodronate Disodium Capsules are a bisphosphonate medication used to inhibit osteoclast-mediated bone resorption. Manufactured by Guangzhou Baiyunshan Mingxing Pharmaceutical Co., Ltd. and approved by China’s NMPA (National Medical Products Administration) under approval number H19980041. ?? Disclaimer:
This product is provided strictly for laboratory research and development use only. Not intended for human or veterinary use. Not for clinical, diagnostic, or therapeutic applications. $2.00 -
Temozolomide Capsules 100?mg × 5 – ChuanNuo (MySean) | Research Grade Glioblastoma Drug
Temozolomide 100?mg capsules, 5?count box, produced by Shanghai ChuanNuo Pharmaceuticals Co., Ltd., approved under NMPA H20234716. A key alkylating agent for glioblastoma and astrocytoma research—ideal for preclinical oncology models.
?? For laboratory research or analytical use only – Not for human consumption or therapeutic use. $1.00
评价
目前还没有评价